Cargando…
Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941738/ https://www.ncbi.nlm.nih.gov/pubmed/27441116 http://dx.doi.org/10.7717/peerj.2163 |
_version_ | 1782442343402569728 |
---|---|
author | Rico-Gomis, José María Palazón-Bru, Antonio Triano-García, Irene Mahecha-García, Luis Fabián García-Monsalve, Ana Navarro-Ruiz, Andrés Villagordo-Peñalver, Berta Jiménez-Abril, Jessica Martínez-Hortelano, Alicia Gil-Guillén, Vicente Francisco |
author_facet | Rico-Gomis, José María Palazón-Bru, Antonio Triano-García, Irene Mahecha-García, Luis Fabián García-Monsalve, Ana Navarro-Ruiz, Andrés Villagordo-Peñalver, Berta Jiménez-Abril, Jessica Martínez-Hortelano, Alicia Gil-Guillén, Vicente Francisco |
author_sort | Rico-Gomis, José María |
collection | PubMed |
description | Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166 patients with these characteristics. In these patients, the association between the polymorphism and the presence of the metabolic syndrome was determined by implementing binary logistic regression models adjusted for variables associated with the metabolic syndrome. We did not confirm previous claims that the C allele of the polymorphism was linked to the metabolic syndrome: the association was in the opposite direction and non-significant. This conclusion held after taking gender and lifestyle variables into account. |
format | Online Article Text |
id | pubmed-4941738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49417382016-07-20 Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics Rico-Gomis, José María Palazón-Bru, Antonio Triano-García, Irene Mahecha-García, Luis Fabián García-Monsalve, Ana Navarro-Ruiz, Andrés Villagordo-Peñalver, Berta Jiménez-Abril, Jessica Martínez-Hortelano, Alicia Gil-Guillén, Vicente Francisco PeerJ Diabetes and Endocrinology Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166 patients with these characteristics. In these patients, the association between the polymorphism and the presence of the metabolic syndrome was determined by implementing binary logistic regression models adjusted for variables associated with the metabolic syndrome. We did not confirm previous claims that the C allele of the polymorphism was linked to the metabolic syndrome: the association was in the opposite direction and non-significant. This conclusion held after taking gender and lifestyle variables into account. PeerJ Inc. 2016-07-07 /pmc/articles/PMC4941738/ /pubmed/27441116 http://dx.doi.org/10.7717/peerj.2163 Text en ©2016 Rico-Gomis et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Diabetes and Endocrinology Rico-Gomis, José María Palazón-Bru, Antonio Triano-García, Irene Mahecha-García, Luis Fabián García-Monsalve, Ana Navarro-Ruiz, Andrés Villagordo-Peñalver, Berta Jiménez-Abril, Jessica Martínez-Hortelano, Alicia Gil-Guillén, Vicente Francisco Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title | Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title_full | Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title_fullStr | Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title_full_unstemmed | Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title_short | Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
title_sort | association between the htr2c rs1414334 c/g gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941738/ https://www.ncbi.nlm.nih.gov/pubmed/27441116 http://dx.doi.org/10.7717/peerj.2163 |
work_keys_str_mv | AT ricogomisjosemaria associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT palazonbruantonio associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT trianogarciairene associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT mahechagarcialuisfabian associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT garciamonsalveana associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT navarroruizandres associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT villagordopenalverberta associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT jimenezabriljessica associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT martinezhortelanoalicia associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics AT gilguillenvicentefrancisco associationbetweenthehtr2crs1414334cggenepolymorphismandthedevelopmentofthemetabolicsyndromeinpatientstreatedwithatypicalantipsychotics |